Ecph
Dallas, US · Founded 2017 · Delaware LLC
Founders & leadership
EA
Eric AndersonDirector and Chief Executive Officer of ECPH, LLC
CB
C. Brett BurfordChief Financial Officer of ECPH, LLC
CF
Chase FinleyPresident and Chief Operating Officer of ECPH, LLC
JS
Jeff S. FronterhouseDirector and Authorized Officer of ECPH, LLC
JB
James BradfordChief Financial Officer of ECPH, LLC
Board
FB
F. Barron Fletcher IIIDirector and Authorized Officer of ECPH, LLC
GG
George GebhardtDirector of ECPH, LLC
JB
Jeff BrowningDirector of ECPH, LLC
JK
John K. CarlyleChairman and Director of ECPH, LLC
DC
David CarrigDirector of ECPH, LLC
JB
Jay BradfordDirector of ECPH, LLC
GA
Glenn Askew IIIDirector and Authorized Officer of ECPH, LLC
Reported raises · per SEC filings
Form D private placements$301.4M disclosed across 9 rounds · 2017–2022
▶$74.6MraisedMay 2026 · 277 investors · Other Health CareRule 506(b)
▶$74.6MraisedMay 2026 · 277 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Richard ParrExecutive Officer
- Eric AndersonExecutive Officer, Director
- F. Barron Fletcher IIIExecutive Officer, Director
- George GebhardtDirector
- C. Brett BurfordExecutive Officer
- Jeff BrowningDirector
- John K. CarlyleExecutive Officer, Director
- David CarrigDirector
- Chase FinleyExecutive Officer
- Tracey McCarthyExecutive Officer
- Jay BradfordDirector
- Jeff S. FronterhouseExecutive Officer, Director
- Amount sold
- $74.6M
- First sale
- May 2022
- Incorporated
- Limited Liability Company, Delaware
- Federal exemptions
- 06b
▶$250KraisedAug 2021 · 1 investors · Other Health CareRule 506(b)
▶$250KraisedAug 2021 · 1 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- George GebhardtDirector
- John CarlyleDirector
- James BradfordExecutive Officer
- Glenn Askew IIIExecutive Officer, Director
- F. Barron Fletcher IIIExecutive Officer, Director
- Jeff BrowningDirector
- Eric AndersonExecutive Officer, Director
- Jeff S. FronterhouseExecutive Officer, Director
- David CarrigDirector
- Offering amount
- $15M
- Amount sold
- $250K
- First sale
- Aug 2021
- Incorporated
- Limited Liability Company, Delaware, 2017
- Federal exemptions
- 06b
▶$115.3MraisedMay 2021 · 5 investors · Other Health CareRule 506(b)
▶$115.3MraisedMay 2021 · 5 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Jeff S. FronterhouseExecutive Officer, Director
- F. Barron Fletcher IIIExecutive Officer, Director
- George GebhardtDirector
- Jeff BrowningDirector
- David CarrigDirector
- Eric AndersonExecutive Officer, Director
- James BradfordExecutive Officer
- Glenn Askew IIIExecutive Officer, Director
- John CarlyleDirector
- Offering amount
- $165M
- Amount sold
- $115.3M
- Finders' fees
- $1.4M
- Proceeds to insiders
- $1.5M
- Placement agents
- Evercore Group L.L.C.
- First sale
- May 2021
- Incorporated
- Limited Liability Company, Delaware, 2017
- Federal exemptions
- 06b
▶$9.5MraisedDec 2020 · 31 investors · Other Health CareRule 506(b)
▶$9.5MraisedDec 2020 · 31 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- James BradfordExecutive Officer
- John CarlyleDirector
- David CarrigDirector
- Eric AndersonExecutive Officer, Director
- George GebhardtDirector
- Glenn Askew IIIExecutive Officer, Director
- F. Barron Fletcher IIIExecutive Officer, Director
- Jeff S. FronterhouseExecutive Officer, Director
- Jeff BrowningDirector
- Offering amount
- $21M
- Amount sold
- $9.5M
- First sale
- Feb 2020
- Incorporated
- Limited Liability Company, Delaware, 2017
- Federal exemptions
- 06b
▶$12.5MraisedJul 2020 · 21 investors · Other Health CareRule 506(b)
▶$12.5MraisedJul 2020 · 21 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- F. Barron Fletcher IIIExecutive Officer, Director
- David CarrigDirector
- John CarlyleDirector
- Jeff S. FronterhouseExecutive Officer, Director
- Jay BradfordExecutive Officer
- Jeff BrowningDirector
- George GebhardtDirector
- Eric AndersonExecutive Officer, Director
- Glenn Askew IIIExecutive Officer, Director
- Offering amount
- $12.5M
- Amount sold
- $12.5M
- First sale
- Jun 2020
- Incorporated
- Limited Liability Company, Delaware, 2017
- Federal exemptions
- 06b
▶$180KraisedJul 2019 · 1 investors · Other Health CareRule 506(b)
▶$180KraisedJul 2019 · 1 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Eric AndersonExecutive Officer, Director
- Warren MeyerDirector
- John CarlyleDirector
- John PittsExecutive Officer
- F. Barron Fletcher IIIExecutive Officer, Director
- Glenn Askew IIIExecutive Officer, Director
- Jeff BrowningDirector
- George GebhardtDirector
- Jeff S. FronterhouseExecutive Officer, Director
- Offering amount
- $10M
- Amount sold
- $180K
- First sale
- Jun 2019
- Incorporated
- Limited Liability Company, Delaware, 2017
- Federal exemptions
- 06b
▶$1.5MraisedMar 2019 · 17 investors · Other Health CareRule 506(b)
▶$1.5MraisedMar 2019 · 17 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- F. Barron Fletcher IIIExecutive Officer, Director
- Jeff S. FronterhouseExecutive Officer, Director
- Warren MeyerDirector
- John CarlyleDirector
- Jeff BrowningDirector
- Eric AndersonExecutive Officer, Director
- George GebhardtDirector
- John PittsExecutive Officer
- Glenn Askew IIIExecutive Officer, Director
- Offering amount
- $4M
- Amount sold
- $1.5M
- First sale
- Mar 2019
- Incorporated
- Limited Liability Company, Delaware, 2017
- Federal exemptions
- 06b
▶$58.3MraisedJan 2019 · 25 investors · Other Health CareRule 506(b)
▶$58.3MraisedJan 2019 · 25 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- F. Barron Fletcher IIIExecutive Officer, Director
- Warren MeyerDirector
- Jeff S. FronterhouseExecutive Officer, Director
- James BradfordExecutive Officer
- John CarlyleDirector
- Eric AndersonExecutive Officer, Director
- Glenn Askew IIIExecutive Officer, Director
- Jeff BrowningDirector
- George GebhardtDirector
- Offering amount
- $58.8M
- Amount sold
- $58.3M
- First sale
- Dec 2018
- Incorporated
- Limited Liability Company, Delaware, 2017
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- How much funding has Ecph raised?
- Ecph has disclosed $301.4M raised across 9 rounds.
- Where is Ecph headquartered?
- Ecph is headquartered in Dallas, US.